Inotiv (NOTVQ) Cash from Restructuring (2022 - 2023)

Inotiv (NOTVQ) posted Cash from Restructuring of $1.3 million for Q3 2023, up 1.0% quarter-over-quarter from $1.3 million in Q2 2023, and down 64.46% year-on-year from $3.7 million in Q3 2022.

Inotiv (NOTVQ) Cash from Restructuring (2022 - 2023) Analysis & Trends

Inotiv (NOTVQ) has reported Cash from Restructuring for 2 consecutive years, with $1.3 million the latest figure, recorded in Q3 2023.

  • Cash from Restructuring for Q3 2023 came in at $1.3 million, down 64.46% year-over-year; the trailing twelve-month figure through Sep 2023 was $11.2 million (changed N/A YoY), and the FY2023 annual result was $4.6 million, down 45.99% from the prior year.
  • Cash from Restructuring was $1.3 million for Q3 2023 at Inotiv, up from $1.3 million in the prior quarter.
  • Over five years, Cash from Restructuring peaked at $4.9 million in Q2 2022 and troughed at $1.3 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Inotiv 346,529.99 -14.83 Mn 111.99 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 1.32 Mn
Jun 30, 2023 1.30 Mn
Sep 30, 2022 3.70 Mn
Jun 30, 2022 4.86 Mn